These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ; Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987 [TBL] [Abstract][Full Text] [Related]
13. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma. Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874 [TBL] [Abstract][Full Text] [Related]
14. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm. Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921 [TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma. Huang Q; Luo K; Chen C; Wang G; Jin J; Kong M; Li B; Liu Q; Li J; Rong T; Chen H; Zhang L; Chen Y; Zhu C; Zheng B; Wen J; Zheng Y; Tan Z; Xie X; Yang H; Fu J J Thorac Oncol; 2016 Apr; 11(4):583-92. PubMed ID: 26792626 [TBL] [Abstract][Full Text] [Related]
16. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study. Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966 [TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit? Gerry JM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Wang TS; Glenn JA; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Hatzaras I; Shenoy R; Pawlik TM; Norton JA; Poultsides GA Ann Surg Oncol; 2016 Dec; 23(Suppl 5):708-713. PubMed ID: 27590329 [TBL] [Abstract][Full Text] [Related]
18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]
19. Reassessing the impact of tumor size on operative approach in adrenocortical carcinoma. Hue JJ; Bingmer K; Zhao H; Ammori JB; Wilhelm SM; Towe CW; Rothermel LD J Surg Oncol; 2021 Apr; 123(5):1238-1245. PubMed ID: 33577722 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E; Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]